23 researcher projects and two student projects at the University of Oslo have been granted seed funding and student support from the Life Science Growth House. We are happy to see so many promising early-stage innovation ideas. We congratulate all who are involved in the projects and look forward to good collaboration!
Since the start in 2016, more than 350 young health science researchers have received training in health innovation through the School of Health Innovation. From 1 June, the Life Science Growth House is in charge of the school at the University of Oslo.
In Norway, we often look to other countries when we talk about innovation and business in the field of life sciences. We still have a lot to learn from other countries, but a lot of good things is happening in the innovation ecosystem for life sciences in Oslo that we can be proud of, and that others are curious about and want to learn from.
Are you a researcher within life sciences, health or technology? Do you have an innovative idea for a new product, solution or technology, but need help to develop it further? The Life Science Growth House can help you take the next steps! Check our call for seed funding. We will grant funding for up to 35 projects. Application deadline: midnight 24 May 2022.
Are you a student within life sciences, health or technology? Do you have an innovative idea for a new product, solution or technology, but need help to develop it further? The Life Science Growth House can help you take the next steps! Check our call. We will grant funding for up to 20 projects. Application deadline: midnight 24 May 2022.
Health and life sciences is one of four thematic areas in Norway's first innovation district Oslo Science City. ‘Oslo Science City and the strong members are important to us. Together, we will develop the Growth House to become an innovation engine in Oslo Science City’, says the director of the Growth House, Hilde Nebb.
Through a number of services from the newly established Life Science Growth House, we facilitate increased innovation in life sciences, health and technology at the University of Oslo (UiO). Our new innovation meeting place for the innovation ecosystem will stimulate networking and collaboration that can contribute to more knowledge from research at UiO being put to use and benefiting patients and society.
The Life Science Growth House and business clusters kick off innovation hangouts where researchers, students and businesses can build networks. In this way, we will facilitate collaboration that puts more research from UiO to use for the benefit of patients and society.
The Life Science Growth House and dScience – Centre for Computational and Data Science will strengthen the innovation culture at UiO and contribute to making Oslo Science Park an even more holistic ecosystem for innovation where business and academia meet. Aim: Put knowledge from research into use!
Do you have an innovation idea in life sciences, or are you wondering if you have an idea? Contact the Life Science Growth House to get access to counselling, seed funding, mentors and meeting places and more to get started on your innovation process.
On 17 February, the Life Science Growth House – the new innovation unit for life sciences at the University of Oslo – was officially opened. The Growth House will help researchers and students with the innovation process. See pictures from the opening where we gathered Oslo’s innovation ecosystem for life sciences.
Inven2, the innovation office of UiO and South-Eastern Norway Regional Health Authority, has contributed to the registration of hundreds of licenses and patents and to the establishment of a large number of companies. The new Life Science Growth House is a low-threshold service that will help even more research being put to use.
Students from medicine, pharmacy and chemistry have the opportunity to get summer jobs in companies through the internship scheme which is supported by the Life Science Growth House. A matchmaking event for companies and students is held 9 February.
EIT Health Scandinavia, part of one of the largest life science initiatives world-wide, is now expanding its network to include University of Oslo (UiO) as an associate partner.
Vegen til betre pasientbehandling, verdiskaping og nye, grøne arbeidsplassar innan livsvitskap og helsenæring går gjennom samarbeid mellom akademia og industri.
Den nye innovasjonsenheten ved UiO – Veksthuset for livsvitenskap – viderefører ordningen med internship for studenter. Bedrifter som vil ta imot studenter, kan nå melde sin interesse for å delta i ordningen. Påmelding for studenter åpner på nyåret.
The new innovation unit the Life Science Growth House at MED and MN will offer guidance and tools to help researchers and students mature early-stage innovation ideas. The unit will create meeting places between academia and business and contribute to strengthening the interaction in UiO's internal and external innovation ecosystem. In this way, the faculties will contribute to a positive innovation culture and to put more knowledge into use. The Life Science Growth House will be launched in February and will open its doors in March 2022.
At the School of Health Innovation, participants gain knowledge, tools and networks that will enhance their ability to solve health challenges and develop the healthcare system.
Scientia Fellows Symposium, inspiring coffee meetings and important publications are some of the highlights of the programme from 2018.
Post.doc Asbjørn Christophersen has spear-headed the work that lead to identification of a narrow phenotype of gluten specific CD4+ T cells. This cell subset is also present in other autoimmune conditions and could be a target for future disease therapy.
Seed funding allocated to help encourage research collaborations across the wider NCMM network.
UiO:Life Science and vice-rector for research and innovation Per Morten Sandset invite all employees at UiO to breakfast meetings 27 May, 28 May, 29 May and 5 June at 8–9 AM.
Five EATRIS members, including NCMM and the Finnish Nordic EMBL partnership node, FIMM, assist reproducibility study
NCMM Associate Investigator, Professor Anne Simonesen, has been named as one of the winners of the King Olav V's Prize for Cancer Research 2019.
A drug development project started by the Taskén Group at NCMM is at the centre of a new and unique co-development agreement between a Norwegian start-up and an Indian pharmaceutical company.